Navigation Links
Morgan & Morgan Announces the Investigation of Hi-Tech Pharmacal Co., Inc. HITK
Date:8/28/2013

NEW YORK, Aug. 28, 2013 /PRNewswire/ -- Morgan & Morgan announces that it is investigating potential legal claims against the board of directors of Hi-Tech Pharmacal Co., Inc. ("Hi-Tech" or the "Company") regarding possible breaches of fiduciary duties and other violations of law related to the sale of the Company to Akorn, Inc., in a transaction valued at approximately $640 million.

If you purchased Hi-Tech, and want more information about the Hi-Tech takeover investigation, please contact George Pressly, Esq. at 1(800) 631-6234 or email George at AskGeorge@morgansecuritieslaw.com.

Morgan & Morgan's investigation concerns whether the Hi-Tech Board of Directors breached their fiduciary duties to stockholders to act in the best interest of Hi-Tech shareholders and to take all necessary steps to ensure that Hi-Tech shareholders receive the maximum value readily available for their shares of Hi-Tech stock. Under the terms of the agreement, shareholders of Hi-Tech will receive $43.50 per share in cash for each share of Hi-Tech they own.

Morgan & Morgan is one of the nation's largest 200 law firms. In addition to securities fraud, the firm also practices in the areas of antitrust, personal injury, consumer protection, wage and hour, and product liability.  All of the Firm's legal endeavors are rooted in its core mission: provide investor and consumer protection and always fight "for the people." 

Attorney advertising. Prior results do not guarantee a similar outcome.

Contact:
Morgan & Morgan
Peter Safirstein, Esq.
28 West 44th Street
Suite 2001
New Yor
'/>"/>

SOURCE Morgan & Morgan
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Luminex Corporation To Present At Morgan Stanley Global Healthcare Conference
2. Thoratec Presentation At Morgan Stanley 2013 Health Care Conference To Be Webcast
3. Hospira to Present at the Morgan Stanley Global Healthcare Conference
4. Austen BioInnovation Institute Gains Funding from The Burton D. Morgan Foundation to Accelerate Biomedical Innovation, Train Young Professionals
5. Morgan & Morgan Announces Investigation of MAP Pharmaceuticals (NASDAQ: MAPP)
6. Phase 3 Topical Drug for Raynauds Disease Available for Licensing/Acquisition at the J.P. Morgan Conference
7. Hospira to Present at the J.P. Morgan 31st Annual Healthcare Conference Jan. 8, 2013
8. SHAREHOLDER ALERT: Morgan & Morgan announces an investigation of Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) and whether senior management and the board of directors violated fiduciary duties owed to Vertex shareholders.
9. Perrigo Company To Present At The Morgan Stanley Global Healthcare Conference
10. Covance to Present at the Morgan Stanley Global Healthcare Conference
11. Amgen To Present At The Morgan Stanley Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... , August 29, 2014 ... participate in the inaugural Tweetchat taking place in ... Worldwide , organised by UBM Live , ... #CPhIChat is a first of its kind global ... across the supply chain, aimed to stimulate conversations ...
(Date:8/28/2014)... Aug. 28, 2014 Reportlinker.com announces ... available in its catalogue: Needle-Free ... http://www.reportlinker.com/p02332847/Needle-Free-Delivery-Technology-and-Market-Forecast-2014-2024.html ... technological and commercial prospects What does the ... Visiongain,s brand new report shows you the ...
(Date:8/28/2014)... 2014 /PRNewswire-iReach/ -- CountryFocus: Healthcare, Regulatory and Reimbursement ... (Photo - http://photos.prnewswire.com/prnh/20140828/140879 ) ... Reimbursement Landscape Poland " an essential source of ... healthcare market and provides insights into the demographic, ... the report provides valuable insights into the trends ...
Breaking Medicine Technology:CPhI Worldwide to Host #CPhIChat Provoking Debate on the Future of Pharma 2CPhI Worldwide to Host #CPhIChat Provoking Debate on the Future of Pharma 3Needle-Free Delivery: Technology and Market Forecast 2014-2024 2Needle-Free Delivery: Technology and Market Forecast 2014-2024 3Needle-Free Delivery: Technology and Market Forecast 2014-2024 4Needle-Free Delivery: Technology and Market Forecast 2014-2024 5Needle-Free Delivery: Technology and Market Forecast 2014-2024 6Needle-Free Delivery: Technology and Market Forecast 2014-2024 7Needle-Free Delivery: Technology and Market Forecast 2014-2024 8Needle-Free Delivery: Technology and Market Forecast 2014-2024 9Needle-Free Delivery: Technology and Market Forecast 2014-2024 10Needle-Free Delivery: Technology and Market Forecast 2014-2024 11Needle-Free Delivery: Technology and Market Forecast 2014-2024 12Needle-Free Delivery: Technology and Market Forecast 2014-2024 13Needle-Free Delivery: Technology and Market Forecast 2014-2024 14Needle-Free Delivery: Technology and Market Forecast 2014-2024 15Needle-Free Delivery: Technology and Market Forecast 2014-2024 16Needle-Free Delivery: Technology and Market Forecast 2014-2024 17Needle-Free Delivery: Technology and Market Forecast 2014-2024 18Poland & Turkey Pharmaceutical Market worth $15 billion & $21.5 billion Respectively by 2020 2Poland & Turkey Pharmaceutical Market worth $15 billion & $21.5 billion Respectively by 2020 3Poland & Turkey Pharmaceutical Market worth $15 billion & $21.5 billion Respectively by 2020 4Poland & Turkey Pharmaceutical Market worth $15 billion & $21.5 billion Respectively by 2020 5
... Pharmaceuticals, Inc. (Nasdaq: ONXX ) today announced ... ASPIRE trial, a Phase 3 international clinical trial evaluating ... dexamethasone in patients with relapsed multiple myeloma.  The company ... Administration (FDA) for a Special Protocol Assessment (SPA) and ...
... 2012  VIVUS, Inc. (NASDAQ: VVUS ) today ... and Metabolic Drugs Advisory Committee recommended Qnexa be granted ... obesity in adults. The Committee voted 20 to 2, on the ... profile. "We are pleased with the panel,s ...
Cached Medicine Technology:Onyx Pharmaceuticals Completes Enrollment in ASPIRE Phase 3 Carfilzomib Combination Trial for the Potential Treatment of Relapsed Multiple Myeloma 2Onyx Pharmaceuticals Completes Enrollment in ASPIRE Phase 3 Carfilzomib Combination Trial for the Potential Treatment of Relapsed Multiple Myeloma 3Onyx Pharmaceuticals Completes Enrollment in ASPIRE Phase 3 Carfilzomib Combination Trial for the Potential Treatment of Relapsed Multiple Myeloma 4Onyx Pharmaceuticals Completes Enrollment in ASPIRE Phase 3 Carfilzomib Combination Trial for the Potential Treatment of Relapsed Multiple Myeloma 5FDA Advisory Committee Recommends Approval of Qnexa® 2FDA Advisory Committee Recommends Approval of Qnexa® 3FDA Advisory Committee Recommends Approval of Qnexa® 4FDA Advisory Committee Recommends Approval of Qnexa® 5
(Date:8/29/2014)... 2 PM US Eastern Time)The current method to ... commonly produced in animals, to neutralize the toxin. ... to difficulties in developing, producing and maintaining the ... led by Charles Shoemaker, Ph.D., professor in the ... the Cummings School of Veterinary Medicine at Tufts ...
(Date:8/29/2014)... AB A new study from the research group of ... and the Lawson Health Research Institute (London, ON) has confirmed ... cancer. The study, published in Cell Reports , shows ... of cancer entirely. , Roughly 2 in 5 Canadians ... of them will die of the disease. In 2014, it,s ...
(Date:8/29/2014)... Francisco, CA (PRWEB) August 30, 2014 ... 10 best web conference providers in the online service ... the list were global leaders Webex, GotoMeeting and Infinite. ... the industry users have to determine which provider is ... Essentially, web conference businesses search for compelling consumer goods ...
(Date:8/29/2014)... Honey Gifts, premium Vancouver adult toys retailer, has ... purse-sized adult toys and erotic products. These products are ... carried in a woman’s purse with complete ease. Not ... Gifts is also leak-free and will not make a ... common characteristics of Honey Gifts’ portable toys range. As ...
(Date:8/29/2014)... 2014 Sansego is an ... interactive online community, and a range of personalized coaching ... the way to professional athletes. Crowie has brought together ... with him throughout the majority of his triathlon career. ... the triathlon public. , Sansego provides the following:, ...
Breaking Medicine News(10 mins):Health News:Mice study shows efficacy of new gene therapy approach for toxin exposures 2Health News:Preventing cancer from forming 'tentacles' stops dangerous spread 2Health News:Top10InAction Reveals Best Web Conference Providers 2Health News:Honey Gifts Now Provides Purse Sized Adult Toys in Vancouver 2Health News:5 x World Champion Triathlete, Craig “Crowie” Alexander, Launches Online Triathlon Coaching Company – Sansego 2Health News:5 x World Champion Triathlete, Craig “Crowie” Alexander, Launches Online Triathlon Coaching Company – Sansego 3
... ANGELES, Sept. 21 Former House Majority leader Tom Delay, who injured ... all on the line when he and dance partner Cheryl Burke, a ... network. , , Last week, Delay was ... in Marina del Rey, Calif. headed by Dr. Robert S. Bray, Jr., ...
... poor decisions long after they were sober , MONDAY, Sept. ... that doing JELL-O shots is never a good idea, adolescent ... risky decisions long after the alcohol had worn off. , ... teenagers who drink to excess could experience similar, long-lasting effects. ...
... , GARDEN CITY, N.Y., Sept. 21 ... Member for District 12 in the Bronx, celebrated an evening ... than 700 residents from Co-Op City joined in the salute ... Mayor David Dinkins, Roscoe Brown, MD, Floyd J. Carter, Bishop ...
... WASHINGTON, Sept. 21 Trust for America,s Health (TFAH) and ... report today featuring a range of evidence-based disease prevention programs ... in communities. , , The Compendium ... and examples from an extensive literature review that NYAM conducted ...
... both open surgery and minimally invasive techniques, study finds ... of nasal fractures is possible using either minimally invasive ... procedure is appropriate for the type of fracture, researchers ... taking into account factors such as fracture type and ...
... care is delayed, complicated and even jeopardized because ... The situation is particularly dire in diverse megacities ... USC computer scientists, communication specialists and health professionals ... speech-to-speech (S2S) translation system for clinics, emergency rooms ...
Cached Medicine News:Health News:Injured Tom Delay to Put Foot to Test in Debut of Dancing With the Stars Premiere Tonight on ABC 2Health News:Drinking in Adolescence May Lead to Risky Choices Later 2Health News:Drinking in Adolescence May Lead to Risky Choices Later 3Health News:HealthCare Partners, IPA, Dr. Richard Merkin, CEO and Councilman Larry Seabrook Celebrate Salute to Our Heroes on 9/11 2Health News:HealthCare Partners, IPA, Dr. Richard Merkin, CEO and Councilman Larry Seabrook Celebrate Salute to Our Heroes on 9/11 3Health News:New Report Highlights Proven Disease Prevention Programs in Communities 2Health News:New Report Highlights Proven Disease Prevention Programs in Communities 3Health News:New Report Highlights Proven Disease Prevention Programs in Communities 4Health News:Best Option for Fractured Nose Varies by Patient 2Health News:'The doctor can understand you now' 2Health News:'The doctor can understand you now' 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: